October, 2022

Questions to ask your lung cancer specialist

If you or someone you care about has been diagnosed with lung cancer, Lung Foundation New Zealand (LFNZ) is here to support you. Here¬†are some examples of questions patients (and carers) might want to ask their specialist; Q. Can we make arrangements to have my tumour tested using comprehensive genomic testing to inform my treatment? […]

Pharmac funds immunotherapy drug Durvalumab for Lung Cancer

Pharmac is now funding a new immunotherapy medicine called durvalumab (Imfinzi) which could be life-changing for the 300 patients diagnosed with Stage 3 non-small cell lung cancer every year in New Zealand.¬†Durvalumab is the first immunotherapy drug to be funded for lung cancer in New Zealand and it has the potential to control cancer beyond […]